WHO ICTRP trial
A phase II, open label, randomized controlled trial for Huosu Yangwei Oral…
ChiCTR1800018132 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800018132 |
|---|---|
| Public title | A phase II, open label, randomized controlled trial for Huosu Yangwei Oral Liquid combined with SOX versus SOX regimen in the treatment of advanced gastric cancer |
| Scientific title | A phase II, open label, randomized controlled trial for Huosu Yangwei Oral Liquid combined with SOX versus SOX regimen in the treatment of advanced gastric cancer |
| Primary sponsor | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Traditional Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Advanced Gastric cancer |
| Interventions | experimental group versus control group:HSYW+SOX versus SOX |
| Registration date | Aug 31, 2018 |
| Target size | experimental group versus control group:170 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: